• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Clinical Research | Clinical Trials & Recruitment | News, Analysis - HIT Consultant

Addressing Health Equity: Practical Solutions to Address Variations in Care

by Syed Hamza Sohail 02/09/2023 Leave a Comment

Addressing Health Equity: Practical Solutions to Address Variations in Care

What You Should Know: - The companies and organizations that comprise the Healthcare Leadership Council (HLC), representing all sectors of the American healthcare industry, have joined in a commitment to advance health equity in the United States including principles and actions to ultimately eliminate health disparities. - The joint commitment follows the release late last year of a report developed by HLC and ZS, a global management and technology consulting firm, identifying multiple
Read More

Curebase Launches Remote First DTx Research Platform

by Syed Hamza Sohail 01/27/2023 Leave a Comment

Curebase-Launches-Remote-First-DTx-Research-Platform

What You Should Know: - Curebase, a company committed to democratizing access to clinical trials, announced the release of its integrated software and services package for digital therapeutics (DTx) trials that accelerates enrollment and allows sponsors to launch their studies faster.  - Available now, the new Curebase offering includes the first one-stop-shop decentralized clinical trial (DCT) platform bundled with site and trial execution services for the DTx market. Making
Read More

Paradigm Launches with $203M to Improve Clinical Research Access

by Syed Hamza Sohail 01/27/2023 Leave a Comment

Paradigm Launches with $203M to Improve Clinical Research Access

What You Should Know: - Paradigm, a healthcare technology company focused on improving access to clinical research for patients, launched with $203 million in Series A funding. - Conceived by ARCH Venture Partners, and co-incubated by ARCH and General Catalyst, Paradigm is rebuilding the clinical research ecosystem by creating a technology-forward clinical trial platform that enables equitable access for all patients by enhancing trial efficiency and reducing the barriers to participation
Read More

Boosting Clinical Trial Recruitment Requires Humanity – and Technology

by Dr. Chris Fourment, SVP of Clinical Strategy at Iterative Health 01/24/2023 Leave a Comment

Boosting Clinical Trial Recruitment Requires Humanity – and Technology

Clinical trials should be a time of promise for better patient outcomes, as they explore new ways to potentially help patients suffering from a variety of conditions. Instead, this phase of treatment development is often met with exasperation as patients, researchers, and drug developers deal with the many barriers to clinical trial recruitment and access.   There are two central – and intrinsically linked – problems with the current state of clinical trial recruitment in the U.S.:
Read More

Alira Health Secures $58M to Expand Global Growth

by Jasmine Pennic 01/09/2023 Leave a Comment

Alira Health Secures $58M to Expand Global Growth

What You Should Know: - Alira Health, a global healthcare advisory, clinical research and technology company, announced it secured an additional $58M in capital funding to accelerate delivery of patient-centric, technology-enabled healthcare solutions. Previously, Alira Health raised $35M in 2021 and $40M in 2022, in two rounds led by Creadev. - Alira Health is focused on new opportunities brought into effect in the United States by federal rules preventing the blocking of electronic
Read More

Real-World Data Startup Crescendo Health Launches with $3.2M

by Fred Pennic 01/06/2023 Leave a Comment

Real-World Data Startup Crescendo Health Launches with $3.2M

What You Should Know: - Crescendo Health, a real-world data startup that's drastically reshaping how clinical researchers get access to hard-to-reach patient data to support their clinical research today officially announced its launch with $3.4M in seed funding from Define Ventures as well as the founders and CEOs of many other well-known organizations. - Founded by the co-founder of Datavant (merged with Ciox in a $7 billion deal), and a top product-management leader from Grand
Read More

Exec Hires: GE HealthCare Names Taha Kass-Hout First Chief Technology Officer

by Jasmine Pennic 01/05/2023 Leave a Comment

Exec Hires: GE HealthCare Names Taha Kass-Hout First Chief Technology Officer

What You Should Know: GE HealthCare announced today that Taha Kass-Hout MD, MS has been named Chief Technology Officer (CTO) to lead the company’s new science and technology organization. - Reporting to GE HealthCare President & CEO Peter Arduini, Dr. Kass-Hout will help drive GE HealthCare’s D3 precision care strategy, a framework and digital products that emphasize the company’s smart devices, aligned to disease states and enabled by digital. D3 brings data and insights together to
Read More

Q/A: Podimetrics CEO Talks Preventing Diabetic Amputations

by Fred Pennic 12/20/2022 Leave a Comment

Q/A: Podimetrics CEO Talks Preventing Diabetic Amputations

Diabetes prevention is one of the biggest challenges in the healthcare industry as more than 37 million Americans (11.3% of the population) suffer from this debilitating chronic disease. As we close the year out, we sat down with Jon Bloom, MD, CEO and Co-founder of diabetic healthcare tech company Podimetrics to learn how the industry and his company are working to implement health equity change to serve patients living with advanced diabetes. The company’s FDA-cleared SmartMat provides a
Read More

Pangea Biomed Adds $5M for its Multi-Cancer Response Predictor

by Syed Hamza Sohail 12/15/2022 Leave a Comment

Pangea Biomed Adds $5M for its Multi-Cancer Response Predictor

What You Should Know: - Pangea Biomed, the biotech company behind ENLIGHT, the multi-cancer response predictor improving the effectiveness of precision oncology, announced $5M in additional funding reaching a total seed round of $12M. - The latest fundraising is led by angel investor Danny Tocatly and existing investor NFX, and will be used to expand US operations, drive commercial partnerships, and scale product offerings. Expanding US Operations and Fostering Commercial
Read More

Clinical Trials: 5 Steps to Greater eConsent Adoption

by Kate Godwin-Smith, Director, Client Services, Patient Consent Solutions, IQVIA Technologies 12/14/2022 Leave a Comment

Clinical Trials: 5 Steps to Greater eConsent Adoption

Clinical trials advance much-needed treatments while offering hope to patients and their families. However, the process of enrolling in a study where they will receive investigational medicines, vaccines or procedures can be a source of friction – enough for patients to rethink participation.  The weight of the decision combined with a perceived lack of transparency of information can confuse or dismay even those patients that are most savvy in the medical industry. Even if they do end
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 17
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |